Drag a card by its title · ⚙ to size, swap or remove

The company

DarioHealth Corp.

DRIO · Nasdaq

Health CareMedical DevicesNot moving yet

DRIO stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 47 weeks. It is 33.2% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 47
Industry in uptrend: 27% -9 in 4 wk
Insider buys, 12 months: $200K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 22 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months0

Buyers · sellers1 · 0

Who	Did	Shares	Traded
Dennis MatheisDirector	bought	14,430at $6.93	23 Jul 2026filed 28 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders22+2 on the quarter

New · exited4 · 2

Reported value$5.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Nantahala Capital Management, LLCadded · filed 14 Aug 2026	610,691$4.0M	+10.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	65,675$433K	-235−0.4%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	58,035$383K	-3,843−6.2%
BlackRock, Inc.added · filed 7 Aug 2026	37,796$249K	+18,978+100.9%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	37,387$247K	+7,317+24.3%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	24,289$160K	+3,829+18.7%
NORTHERN TRUST CORPunchanged · filed 13 Aug 2026	13,237$87K	00.0%
Vanguard Global Advisers, LLCunchanged · filed 13 Aug 2026	3,321$22K	00.0%
MORGAN STANLEYadded · filed 13 Aug 2026	3,000$20K	+2,000+200.0%
OSAIC HOLDINGS, INC.added · filed 14 Aug 2026	1,900$13K	+1,899+189900.0%

30 Sep 2025 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

Adam K. Stern Director · last 24 Sep 202618 · 0

Chen Franco-Yehuda Chief Financial Officer · last 24 Sep 20260 · 0

Dennis M. McGrath Director · last 24 Sep 20260 · 3

Dennis Matheis Director · last 24 Sep 20262 · 0

Erez Raphael Chief Executive Officer · last 24 Sep 202622 · 8

Hila Karah Director · last 24 Sep 202611 · 0

John R. Palumbo Director · last 24 Sep 20260 · 0

Yoav Shaked Director · last 24 Sep 202614 · 0

Lawrence B. Leisure Director · last 11 Sep 20250 · 0

Steven Charles Nelson President and CCO · last 11 Sep 202512 · 0

Jon H. Kaplan Director · last 24 Feb 20250 · 0

Richard Alan Anderson President · last 6 Mar 20240 · 0

Same industry

RCEL Avita MedicalLeading+100%

ATRC AtriCureLeading+49%

HAE HaemoneticsLeading+48%

HTFL HeartflowLeading+40%

PLSE Pulse BiosciencesLeading+33%

INFU InfuSystems HoldingsLeading+27%

SMTI Sanara MedTechLeading+26%

ITGR Integer HoldingsLeading+23%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202556.6%

Operating profit marginFY 2025 · to 31 Dec 2025-164%

Free cash flow marginFY 2025 · to 31 Dec 2025-117%

Return on capital employedFY 2025 · to 31 Dec 2025-36.4%

Debt to equityFY 2025 · to 31 Dec 20250.45×

Research spendFY 2025 · to 31 Dec 202561.7%

Share count trendFY 2025 · to 11 Mar 20265.7%

Cash and equivalentsFY 2025 · to 31 Dec 2025$21.8M

Free cash flowFY 2025 · to 31 Dec 2025−$26.1M

Analyst forecasts

No analyst forecasts yet.